Literature DB >> 18165015

Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.

Urmi Dhagat1, Satoshi Endo, Akira Hara, Ossama El-Kabbani.   

Abstract

Mouse 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) is a member of the aldo-keto reductase superfamily that catalyses the oxido-reduction of steroid hormones such as estrogens, androgens and neurosteroids. Inhibitors of aldose reductase (AR), a member of the same superfamily, were evaluated against AKR1C21. Models of the enzyme-inhibitor complexes suggest that Tyr118 and Phe311 are important residues for inhibitor recognition and orientation in the active site of AKR1C21.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165015     DOI: 10.1016/j.bmc.2007.12.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

2.  Identifying the molecular basis of Jinhong tablets against chronic superficial gastritis via chemical profile identification and symptom-guided network pharmacology analysis.

Authors:  Danfeng Shi; Lingxian Liu; Haibo Li; Dabo Pan; Xiaojun Yao; Wei Xiao; Xinsheng Yao; Yang Yu
Journal:  J Pharm Anal       Date:  2021-01-31

3.  Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice.

Authors:  Matthew Pratt-Hyatt; Andrew J Lickteig; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-05-09       Impact factor: 3.922

Review 4.  Flavonoids from Brazilian Cerrado: Biosynthesis, Chemical and Biological Profile.

Authors:  Josana de Castro Peixoto; Bruno Junior Neves; Flávia Gonçalves Vasconcelos; Hamilton Barbosa Napolitano; Maria Gonçalves da Silva Barbalho; Sandro Dutra E Silva; Lucimar Pinheiro Rosseto
Journal:  Molecules       Date:  2019-08-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.